Saluda Medical Announces First U.S. Surgical Cases Using Newly Approved CAP24™ Paddle Lead

BLOOMINGTON, Minn., July 16, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company"), a commercial‑stage medical device company advancing closed‑loop neuromodulation for chronic neurological conditions, today announced the first U.S. surgical cases using the newly...